Navigation Links
Effective Rx thwarted for deadly opioid epidemic
Date:6/21/2013

WASHINGTON, June 21, 2013 /PRNewswire-USNewswire/ -- State governments and insurance companies are increasingly restricting the use of effective, FDA-approved medications that could help reverse the epidemic of opioid addiction and overdose deaths, according to the most comprehensive reports on opioid addiction medications released today by the American Society of Addiction Medicine (ASAM).

Approximately 4 million U.S. residents are addicted to prescription and illegal opioids. Nearly 15,000 people die every year from overdoses involving pain medications, more than die in drunk driving car crashes. Addiction is a treatable chronic disease with treatment success and relapse rates comparable to other chronic diseases such as diabetes and hypertension. Opioid addiction is best managed with a combination of treatments, including behavioral interventions and medications. The FDA has approved three principal medications for treating opioid addiction: buprenorphine, methadone and naltrexone.

"These reports show that we could be saving lives and effectively treating the disease of addiction if state governments and insurance companies remove roadblocks to the use of these medications," said Stuart Gitlow, MD, President of ASAM. "Treatment professionals need every evidence-based tool available to end suffering from this chronic disease. State lawmakers and insurance company administrators would never deny needed medication to people suffering from other chronic diseases, like diabetes and hypertension. But it happens every day to people with addiction."

Strong evidence of effectiveness
The report on effectiveness of opioid medications, conducted by the Treatment Research Institute, examined 642 unique studies that evaluated buprenorphine, methadone, oral naltrexone and injectable naltrexone. The report found that these medications show substantive evidence of effectiveness and safety.
'/>"/>

SOURCE American Society of Addiction Medicine
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Natural Process Green Coffee Bean Extract Promises Safe, Effective Weight Loss Without Stimulants or Unhealthy Additives
2. Belrose Pharma Acquires Enzons Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies
3. New drug proving effective in attacking advanced prostate cancer
4. Effective Rx thwarted for deadly opiate epidemic
5. Daily 10 milligram dose of S-equol reduces menopausal symptoms effectively without impacting thyroid and sex hormones
6. Aetna, Cardinal Health Specialty Solutions Alliance Delivers More Cost-Effective, Patient-Centered Cancer Care
7. Neiman Center Issues Policy Brief Outlining Innovative Health Care Payment Models to Provide Cost-Effective Specialty Care for Patients
8. BioElectronics Continues FDA Clearance Campaign to Bring Chronic Pain Sufferers Safe, Effective, Inexpensive, Drug-Free Pain Therapy
9. Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak
10. Internal Communication Strategies and Tactics that Resonate with Key Stakeholders and Drive Organizational Effectiveness
11. The MED Group Announces New Agreement with CareCentrix Effective May 1, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... 2014 China Biologic Products, Inc. (NASDAQ: CBPO, ... plasma-based biopharmaceutical company in China , ... quarter 2014 financial results on Tuesday, August 5, 2014 ... management will hold a conference call at 8:00 a.m. ... p.m., Beijing Time on August 6, 2014, to discuss ...
(Date:7/29/2014)... 29, 2014 , Next ... development program has commenced , TPM®/Oxycodone Phase ... during Q4 2014 , TPM®/Oxymorphone Phase 2 ... 1H 2015 Australian drug delivery company, Phosphagenics ... transdermal patch programs after its recent announcement of a $19.2 million ...
(Date:7/29/2014)...   , First patient ... efficacy and safety of MSB0010718C in patients with metastatic Merkel ... aggressive skin cancer lacking effective treatments   MSB0010718C is ... clinical trial for the treatment of solid tumors that aims ... a subsidiary of Merck KGaA, Darmstadt, Germany ...
Breaking Medicine Technology:China Biologic to Report Second Quarter 2014 Financial Results 2China Biologic to Report Second Quarter 2014 Financial Results 3Phosphagenics Provides Update on Opioid Patch Program 2Phosphagenics Provides Update on Opioid Patch Program 3Phosphagenics Provides Update on Opioid Patch Program 4Phosphagenics Provides Update on Opioid Patch Program 5Phosphagenics Provides Update on Opioid Patch Program 6EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma 2EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma 3EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma 4EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma 5
... /Xinhua-PRNewswire/ -- NeuroAid(TM) is the first,natural compound to ... on stroke,recovery starting in the acute stage. ... trial to evaluate the efficacy of NeuroAid(TM) in ... with treatment starting within 48 hours of a ...
... 26 Rcadia Medical Imaging, Ltd.,developer of novel ... Food and Drug Administration (FDA) clearance to market,its ... triaging patients for,coronary artery disease (CAD). The new ... human intervention and automatic detection of,pathologies in the ...
Cached Medicine Technology:International Expert Group Initiates Largest Multi-center Phase III Trial to Evaluate NeuroAid(TM) in Stroke Recovery 2International Expert Group Initiates Largest Multi-center Phase III Trial to Evaluate NeuroAid(TM) in Stroke Recovery 3International Expert Group Initiates Largest Multi-center Phase III Trial to Evaluate NeuroAid(TM) in Stroke Recovery 4Rcadia's COR Analyzer Family of Products Receives Second FDA Clearance 2
(Date:7/29/2014)... 2014 This Latest Guidebook for Conducting ... (2014 Edition) not only provided a comprehensive and thorough ... for imported drug registration but also introduced the practical ... guide you to use the Chinese trial venues to ... world step by step. , The audiences of this ...
(Date:7/29/2014)... (PRWEB) July 29, 2014 The ... (SQL, Nosql), Software (Database Application Builder, Data Scaling ... Models (Iaas, Paas, Dbaas) and Service Models (Public ... & Organization Size (Small And Medium, Large) - ... and segments the global cloud database and DBaaS ...
(Date:7/29/2014)... repeatedly shown that death rates rise in association with ... in the summer of 2003, for example, resulted in ... by Dr. Alex-andra Schneider at the Institute of Epidemiology ... of extreme temperatures on the number of deaths caused ... both high and low temperatures in the study. , ...
(Date:7/29/2014)... July 29, 2014 CRN International has ... Services Operation. , Christina Upton, an 11-year veteran at ... Client Services responsible for managing the day-to-day execution of ... at the center of all activities for CRN clients, ... in the world . The department interfaces directly with ...
(Date:7/29/2014)... Dallas, Texas (PRWEB) July 29, 2014 ... the Global Biosimilars Market report is an essential ... biosimilars industry. Using detailed company data, financial analysis, ... in-depth analysis of the current and future growth ... the various regulatory frameworks under which biosimilars are ...
Breaking Medicine News(10 mins):Health News:Pharma Clinical Trials Market in China: Authorities for Drug New Study Now Available at MarketReportsOnline.com 2Health News:Pharma Clinical Trials Market in China: Authorities for Drug New Study Now Available at MarketReportsOnline.com 3Health News:Pharma Clinical Trials Market in China: Authorities for Drug New Study Now Available at MarketReportsOnline.com 4Health News:Cloud Database and DBaaS Market by Databases Worth $14.05 Billion by 2019 - New Report by MarketsandMarkets 2Health News:Cloud Database and DBaaS Market by Databases Worth $14.05 Billion by 2019 - New Report by MarketsandMarkets 3Health News:Cloud Database and DBaaS Market by Databases Worth $14.05 Billion by 2019 - New Report by MarketsandMarkets 4Health News:Cloud Database and DBaaS Market by Databases Worth $14.05 Billion by 2019 - New Report by MarketsandMarkets 5Health News:Mortality rates increase due to extreme heat and cold 2Health News:CRN International Names New Director to Lead Client Services Department 2Health News:World Biosimilars Market Value Exceed $262 Billion by 2019 Says a New Report Available at MarketOptimizer.org 2Health News:World Biosimilars Market Value Exceed $262 Billion by 2019 Says a New Report Available at MarketOptimizer.org 3Health News:World Biosimilars Market Value Exceed $262 Billion by 2019 Says a New Report Available at MarketOptimizer.org 4
... state Health Directorate officials have confirmed that there has ... fever in about 29// villages of Nasik district. Around ... have been hospitalized. ,Malegon was the worst ... were sent to the National Institute of Virology (NIV), ...
... physician from Philadelphia has come out with a ... from arthritis. The technique when used will ease ... ,Interventional radiologist Kevin Baskin of Children's Hospital ... ankle joint of juvenile arthritis patients at the ...
... Pakistan's 155 million population carries the deadly hepatitis virus, ... ,"Hepatitis B and C is a time bomb ... to control it," said the president of the Pakistan ... 2006 report. ,The association represents medical practitioners ...
... in Hypertension: Journal of the American Heart Association sleeping ... may increase risks of high blood pressure. // Columbia ... of Physicians and Surgeons conducted the study. ... at Columbia University's Mailman School of Public Health reported ...
... covering the provinces of Luanda, Bengo, Benguela, and Kwanza Norte. ... 13, the number of reported cases has risen to 2,026 ... Sunday WHO representative, Angola Fatoumata Diallo handed over 7 ... of Health Jose Van- Dunem. ,The National Laboratory ...
... showed that ROZEREM? (ramelteon) could be used for treating people ... reduce the time to fall asleep in adults significantly. // ... showed no signs of recurring or withdrawal effects. ... 8 mg of ROZEREM experienced at least a 50 percent ...
Cached Medicine News:Health News:ROZEREM? Can Be A Better Option For Insomnia Patients 2Health News:ROZEREM? Can Be A Better Option For Insomnia Patients 3Health News:ROZEREM? Can Be A Better Option For Insomnia Patients 4
A custom blend for Applied Biosystems by FMC. Designed specifically for the electrophoresis of PCR products....
... for screening donors on the PK7200 Automated ... CMV antigen attached to a gelatin particle ... and specificity of the CMV assay as ... respectively. The use of a gelatin particle ...
The Ortho AutoVue System is an automated immunohematology testing system used for blood typing, antibody screening and compatibility testing using Ortho BioVue System cassettes....
... designed for medium to ... centers and reference laboratories ... antibody screening. It will ... functions including blood group ...
Medicine Products: